Annual report pursuant to Section 13 and 15(d)

Acquisitions - Schedule of Intangible Assets Acquired (Details)

v3.20.1
Acquisitions - Schedule of Intangible Assets Acquired (Details) - USD ($)
 3 Months Ended 12 Months Ended
Sep. 30, 2018
Jun. 30, 2018
Dec. 31, 2018
Jun. 30, 2019
Jun. 29, 2019
Feb. 16, 2018
Nov. 17, 2017
Measurement Period Adjustments              
Intangible assets     $ 6,000        
Avadel              
Business Acquisition [Line Items]              
Intangible assets           $ 18,291,000  
Measurement Period Adjustments              
Intangible assets   $ 1,838,000          
TRx              
Business Acquisition [Line Items]              
Intangible assets             $ 19,596,000
Measurement Period Adjustments              
Intangible assets $ 1,528,000            
PAI Sales & Marketing Agreement | TRx              
Business Acquisition [Line Items]              
Intangible assets             2,553,000
Measurement Period Adjustments              
Intangible assets 219,000            
Karbinal | Acquired Product Marketing Rights | Avadel              
Business Acquisition [Line Items]              
Intangible assets           6,200,000  
Measurement Period Adjustments              
Intangible assets   (21,000)          
AcipHex | Acquired Product Marketing Rights | Avadel              
Business Acquisition [Line Items]              
Intangible assets           2,803,000  
Measurement Period Adjustments              
Intangible assets   283,000          
Cefaclor | Acquired Product Marketing Rights | Avadel              
Business Acquisition [Line Items]              
Intangible assets           7,611,000  
Measurement Period Adjustments              
Intangible assets   1,320,000          
Flexichamber | Acquired Developed Technology | Avadel              
Business Acquisition [Line Items]              
Intangible assets       $ 0 $ 1,400,000 1,677,000  
Measurement Period Adjustments              
Intangible assets   546,000          
LiquiTime Process | In Process Research and Development | Avadel              
Business Acquisition [Line Items]              
Intangible assets           0  
Measurement Period Adjustments              
Intangible assets   $ (290,000)          
Metafolin | Acquired Product Marketing Rights | TRx              
Business Acquisition [Line Items]              
Intangible assets             11,987,000
Measurement Period Adjustments              
Intangible assets 1,522,000            
Millipred | Acquired Product Marketing Rights | TRx              
Business Acquisition [Line Items]              
Intangible assets             5,056,000
Measurement Period Adjustments              
Intangible assets 342,000            
Ulesfia | Acquired Product Marketing Rights | TRx              
Business Acquisition [Line Items]              
Intangible assets             0
Measurement Period Adjustments              
Intangible assets $ (555,000)            
Previously Reported | Avadel              
Business Acquisition [Line Items]              
Intangible assets           16,453,000  
Previously Reported | TRx              
Business Acquisition [Line Items]              
Intangible assets             18,068,000
Previously Reported | PAI Sales & Marketing Agreement | TRx              
Business Acquisition [Line Items]              
Intangible assets             2,334,000
Previously Reported | Karbinal | Acquired Product Marketing Rights | Avadel              
Business Acquisition [Line Items]              
Intangible assets           6,221,000  
Previously Reported | AcipHex | Acquired Product Marketing Rights | Avadel              
Business Acquisition [Line Items]              
Intangible assets           2,520,000  
Previously Reported | Cefaclor | Acquired Product Marketing Rights | Avadel              
Business Acquisition [Line Items]              
Intangible assets           6,291,000  
Previously Reported | Flexichamber | Acquired Developed Technology | Avadel              
Business Acquisition [Line Items]              
Intangible assets           1,131,000  
Previously Reported | LiquiTime Process | In Process Research and Development | Avadel              
Business Acquisition [Line Items]              
Intangible assets           $ 290,000  
Previously Reported | Metafolin | Acquired Product Marketing Rights | TRx              
Business Acquisition [Line Items]              
Intangible assets             10,465,000
Previously Reported | Millipred | Acquired Product Marketing Rights | TRx              
Business Acquisition [Line Items]              
Intangible assets             4,714,000
Previously Reported | Ulesfia | Acquired Product Marketing Rights | TRx              
Business Acquisition [Line Items]              
Intangible assets             $ 555,000